NCT Number: NCT00353795
Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI)
The overall goal of this study is to use MRI to:
* Examine the relationship between known risk factors for cardiovascular disease and coronary artery wall thickness; * Examine the relationship between coronary artery wall thickness and other markers of subclinical coronary atherosclerosis, such as carotid wall thickness and coronary calcium scores; and, * Examine the feasibility of measuring the progression of coronary artery wall thickness over time in a subset of participants.
Looking for future studies?
Notify MeKey information
Conditions
Age range
45 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Northwestern University MESA Field Center, Chicago, Illinois, United States
About this study
Each enrolled participant will undergo MR Imaging of the coronary arteries in conjunction with their routine MESA follow-up visit. The MRI will last approximately 45-60 minutes
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Prior enrollment in the MESA Study at the Hopkins MESA Field Center or the Northwestern University MESA Field Center
- Male or Female adult equal to or older than 45 years of age
- Willing/able to provide informed consent
Exclusion criteria
- Any known contraindications to MRI (i.e. severe claustrophobia, pacemaker, etc.)
- Metal in the eyes
Treatment and study plan
Primary outcomes
-
Mean Coronary Wall Thickness
Time frame: n/a (cross sectional analysis)
Average thickness of the wall of the left anterior descending, right and left main coronary artery measured by magnetic resonance imaging (MRI).
Sponsors and collaborators
Lead sponsor
Johns Hopkins University
Other
Collaborators
- Northwestern University
Registry information
Official study title
Coronary Atherosclerosis Evaluation by Arterial Wall MRI
Important dates
- Study start
- 2005
- Primary completion
- 2008
- Study completion
- 2008
- First posted
- Jul 19, 2006
- Registry last updated
- Jun 22, 2010
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Comparison of Agent™ and SeQuent® Please Paclitaxel Coated Balloon Catheters in Coronary In-stent Restenosis (AGENT-ISR)
NCT02151812
Arterial Occlusive Diseases, Arteriosclerosis
Lyon, France
View Trial DetailsCombination Stem Cell Therapy for the Treatment of Severe Coronary Ischemia
NCT00643981
Arterial Occlusive Diseases, Arteriosclerosis
Covington, Louisiana, United States
View Trial DetailsCombination Stem Cell (MESENDO) Therapy for Utilization and Rescue of Infarcted Myocardium
NCT00548613
Arterial Occlusive Diseases, Arteriosclerosis
Covington, Louisiana, United States
View Trial DetailsPower Walking in Cardiac Patients Who Underwent Post-coronary Angioplasty
NCT04610060
Angina Pectoris, Angina, Unstable
Ajman, United Arab Emirates
View Trial Details